Erythropoietin Stimulating Agents Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: E2D15C5F5E99EN
Market Monitor Global

Abstracts

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.

This report contains market size and forecasts of Erythropoietin Stimulating Agents in Global, including the following market information:

Global Erythropoietin Stimulating Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Erythropoietin Stimulating Agents market was valued at 6111 million in 2021 and is projected to reach US$ 6663.4 million by 2028, at a CAGR of 1.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Epoetin Alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Erythropoietin Stimulating Agents include Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson and Johnson and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erythropoietin Stimulating Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Erythropoietin Stimulating Agents Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Erythropoietin Stimulating Agents Market Segment Percentages, by Type, 2021 (%)

• Epoetin Alfa
• Epoetin Beta
• Darbepoetin Alfa
• Others

Global Erythropoietin Stimulating Agents Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Erythropoietin Stimulating Agents Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Erythropoietin Stimulating Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Erythropoietin Stimulating Agents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Erythropoietin Stimulating Agents revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Erythropoietin Stimulating Agents revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Amgen
• BioSidus
• Biocon
• Celltrion
• Roche
• Intas Pharmaceuticals
• Johnson and Johnson
• Teva Pharmaceutical Industries
• Thermo Fisher Scientific

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Erythropoietin Stimulating Agents Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Erythropoietin Stimulating Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ERYTHROPOIETIN STIMULATING AGENTS OVERALL MARKET SIZE

2.1 Global Erythropoietin Stimulating Agents Market Size: 2021 VS 2028
2.2 Global Erythropoietin Stimulating Agents Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Erythropoietin Stimulating Agents Players in Global Market
3.2 Top Global Erythropoietin Stimulating Agents Companies Ranked by Revenue
3.3 Global Erythropoietin Stimulating Agents Revenue by Companies
3.4 Top 3 and Top 5 Erythropoietin Stimulating Agents Companies in Global Market, by Revenue in 2021
3.5 Global Companies Erythropoietin Stimulating Agents Product Type
3.6 Tier 1, Tier 2 and Tier 3 Erythropoietin Stimulating Agents Players in Global Market
  3.6.1 List of Global Tier 1 Erythropoietin Stimulating Agents Companies
  3.6.2 List of Global Tier 2 and Tier 3 Erythropoietin Stimulating Agents Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Erythropoietin Stimulating Agents Market Size Markets, 2021 & 2028
  4.1.2 Epoetin Alfa
  4.1.3 Epoetin Beta
  4.1.4 Darbepoetin Alfa
  4.1.5 Others
4.2 By Type - Global Erythropoietin Stimulating Agents Revenue & Forecasts
  4.2.1 By Type - Global Erythropoietin Stimulating Agents Revenue, 2017-2022
  4.2.2 By Type - Global Erythropoietin Stimulating Agents Revenue, 2023-2028
  4.2.3 By Type - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Erythropoietin Stimulating Agents Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Erythropoietin Stimulating Agents Revenue & Forecasts
  5.2.1 By Application - Global Erythropoietin Stimulating Agents Revenue, 2017-2022
  5.2.2 By Application - Global Erythropoietin Stimulating Agents Revenue, 2023-2028
  5.2.3 By Application - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Erythropoietin Stimulating Agents Market Size, 2021 & 2028
6.2 By Region - Global Erythropoietin Stimulating Agents Revenue & Forecasts
  6.2.1 By Region - Global Erythropoietin Stimulating Agents Revenue, 2017-2022
  6.2.2 By Region - Global Erythropoietin Stimulating Agents Revenue, 2023-2028
  6.2.3 By Region - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Erythropoietin Stimulating Agents Revenue, 2017-2028
  6.3.2 US Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.3.3 Canada Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.3.4 Mexico Erythropoietin Stimulating Agents Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Erythropoietin Stimulating Agents Revenue, 2017-2028
  6.4.2 Germany Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.4.3 France Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.4.4 U.K. Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.4.5 Italy Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.4.6 Russia Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.4.7 Nordic Countries Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.4.8 Benelux Erythropoietin Stimulating Agents Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Erythropoietin Stimulating Agents Revenue, 2017-2028
  6.5.2 China Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.5.3 Japan Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.5.4 South Korea Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.5.5 Southeast Asia Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.5.6 India Erythropoietin Stimulating Agents Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Erythropoietin Stimulating Agents Revenue, 2017-2028
  6.6.2 Brazil Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.6.3 Argentina Erythropoietin Stimulating Agents Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue, 2017-2028
  6.7.2 Turkey Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.7.3 Israel Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.7.4 Saudi Arabia Erythropoietin Stimulating Agents Market Size, 2017-2028
  6.7.5 UAE Erythropoietin Stimulating Agents Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Erythropoietin Stimulating Agents Major Product Offerings
  7.1.4 Pfizer Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Erythropoietin Stimulating Agents Major Product Offerings
  7.2.4 Amgen Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 BioSidus
  7.3.1 BioSidus Corporate Summary
  7.3.2 BioSidus Business Overview
  7.3.3 BioSidus Erythropoietin Stimulating Agents Major Product Offerings
  7.3.4 BioSidus Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.3.5 BioSidus Key News
7.4 Biocon
  7.4.1 Biocon Corporate Summary
  7.4.2 Biocon Business Overview
  7.4.3 Biocon Erythropoietin Stimulating Agents Major Product Offerings
  7.4.4 Biocon Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.4.5 Biocon Key News
7.5 Celltrion
  7.5.1 Celltrion Corporate Summary
  7.5.2 Celltrion Business Overview
  7.5.3 Celltrion Erythropoietin Stimulating Agents Major Product Offerings
  7.5.4 Celltrion Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.5.5 Celltrion Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Erythropoietin Stimulating Agents Major Product Offerings
  7.6.4 Roche Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News
7.7 Intas Pharmaceuticals
  7.7.1 Intas Pharmaceuticals Corporate Summary
  7.7.2 Intas Pharmaceuticals Business Overview
  7.7.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Major Product Offerings
  7.7.4 Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.7.5 Intas Pharmaceuticals Key News
7.8 Johnson and Johnson
  7.8.1 Johnson and Johnson Corporate Summary
  7.8.2 Johnson and Johnson Business Overview
  7.8.3 Johnson and Johnson Erythropoietin Stimulating Agents Major Product Offerings
  7.8.4 Johnson and Johnson Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.8.5 Johnson and Johnson Key News
7.9 Teva Pharmaceutical Industries
  7.9.1 Teva Pharmaceutical Industries Corporate Summary
  7.9.2 Teva Pharmaceutical Industries Business Overview
  7.9.3 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Major Product Offerings
  7.9.4 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.9.5 Teva Pharmaceutical Industries Key News
7.10 Thermo Fisher Scientific
  7.10.1 Thermo Fisher Scientific Corporate Summary
  7.10.2 Thermo Fisher Scientific Business Overview
  7.10.3 Thermo Fisher Scientific Erythropoietin Stimulating Agents Major Product Offerings
  7.10.4 Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
  7.10.5 Thermo Fisher Scientific Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Erythropoietin Stimulating Agents Market Opportunities & Trends in Global Market
Table 2. Erythropoietin Stimulating Agents Market Drivers in Global Market
Table 3. Erythropoietin Stimulating Agents Market Restraints in Global Market
Table 4. Key Players of Erythropoietin Stimulating Agents in Global Market
Table 5. Top Erythropoietin Stimulating Agents Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Erythropoietin Stimulating Agents Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Erythropoietin Stimulating Agents Revenue Share by Companies, 2017-2022
Table 8. Global Companies Erythropoietin Stimulating Agents Product Type
Table 9. List of Global Tier 1 Erythropoietin Stimulating Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Erythropoietin Stimulating Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Erythropoietin Stimulating Agents Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Erythropoietin Stimulating Agents Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Erythropoietin Stimulating Agents Product Offerings
Table 32. Pfizer Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Erythropoietin Stimulating Agents Product Offerings
Table 35. Amgen Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 36. BioSidus Corporate Summary
Table 37. BioSidus Erythropoietin Stimulating Agents Product Offerings
Table 38. BioSidus Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 39. Biocon Corporate Summary
Table 40. Biocon Erythropoietin Stimulating Agents Product Offerings
Table 41. Biocon Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 42. Celltrion Corporate Summary
Table 43. Celltrion Erythropoietin Stimulating Agents Product Offerings
Table 44. Celltrion Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Erythropoietin Stimulating Agents Product Offerings
Table 47. Roche Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 48. Intas Pharmaceuticals Corporate Summary
Table 49. Intas Pharmaceuticals Erythropoietin Stimulating Agents Product Offerings
Table 50. Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 51. Johnson and Johnson Corporate Summary
Table 52. Johnson and Johnson Erythropoietin Stimulating Agents Product Offerings
Table 53. Johnson and Johnson Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Industries Corporate Summary
Table 55. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product Offerings
Table 56. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
Table 57. Thermo Fisher Scientific Corporate Summary
Table 58. Thermo Fisher Scientific Erythropoietin Stimulating Agents Product Offerings
Table 59. Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Erythropoietin Stimulating Agents Segment by Type in 2021
Figure 2. Erythropoietin Stimulating Agents Segment by Application in 2021
Figure 3. Global Erythropoietin Stimulating Agents Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Erythropoietin Stimulating Agents Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Erythropoietin Stimulating Agents Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Erythropoietin Stimulating Agents Revenue in 2021
Figure 8. By Type - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 9. By Application - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 10. By Region - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 11. By Country - North America Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 12. US Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 16. Germany Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 17. France Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 24. China Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 28. India Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 30. Brazil Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
Figure 33. Turkey Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioSidus Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biocon Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celltrion Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson and Johnson Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)